Calgary Herald

AZ version missing on vaccine passport

European document snubs India-made shot

- MIRIAM BERGER

The European Union's much anticipate­d coronaviru­s digital certificat­e, intended to ease travel across the continent for the vaccinated, began Thursday amid widespread confusion.

But many would-be travellers — particular­ly those from poorer countries — do not meet the program's criteria because they received Astrazenec­a shots produced by India's Serum Institute, which has not been approved by EU regulators.

The Serum Institute, however, is approved by the World Health Organizati­on and is a major supplier to the Covax initiative, which is intended to ensure an equitable distributi­on of coronaviru­s vaccines and is a main procurer of doses for many poorer countries.

As of Wednesday, only four Western-produced vaccines qualify under the EU certificat­e's criteria: Moderna, Pfizer-biontech, Johnson & Johnson and Astrazenec­a doses, also called Vaxzevria, manufactur­ed in Europe by Astrazenec­a, which developed the vaccine with Oxford University.

Not on the list is the Serum Institute's Astrazenec­a vaccine version, called Covishield, as it is not approved by the European Medicines Agency, the European Union's medical regulatory body.

WHO and Covax issued a joint statement Thursday criticizin­g as “counter-effective” vaccine travel certificat­es that do not include all Who-sanctioned versions.

“Any measure that only allows people protected by a subset of Who-approved vaccines to benefit from the reopening of travel into and with that region would effectivel­y create a two-tier system, further widening the global vaccine divide and exacerbati­ng the inequities we have already seen in the distributi­on of COVID-19 vaccines,” the statement said. “It would negatively impact the growth of economies that are already suffering the most.”

Serum Institute chief executive Adar Poonawalla said Monday that he was working to resolve the issue as fast as possible. The institute has applied for EMA authorizat­ion. The Serum Institute's shots are chemically the same as those produced in Europe.

 ?? SUMIT DAYAL / BLOOMBERG ?? A health workers administer­s a dose of the Covishield vaccine, manufactur­ed by the Serum Institute of India,
at a vaccinatio­n centre in New Delhi.
SUMIT DAYAL / BLOOMBERG A health workers administer­s a dose of the Covishield vaccine, manufactur­ed by the Serum Institute of India, at a vaccinatio­n centre in New Delhi.

Newspapers in English

Newspapers from Canada